Botulinum Toxin for the Treatment of Involuntary Movement Disorders
Part of paid clinical trials in Bethesda, Maryland.
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Study ID
- NCT00001208
- Status
- Recruiting
Conditions
- Movement Disorders
Eligibility Criteria
- Sex
- ALL
- Age
- 2 Years - 100 Years
- Healthy Volunteers
- Not accepted
Study Details
BTX has been used since the 1980s in support of the research mission of NINDS. Initial studies were focused on expanding the applicability of BTX treatment to movement disorders and exploring new indications. We evaluated the efficacy of an alternative serotype, type F. Under other protocols, we continue to study the physiology of movement disorders and BTX response. The application of BTX therapy to movement disorders requires an understanding of BTX preparation and handling. The treatment must be tailored to the disorder under treatment and to its expression in the individual patient. Users must know the specific techniques of injection, including the use of EMG and ultrasound guidance. This protocol allows us to train physicians in all aspects of the use of BTX. It also provides us with a cohort of patients, receiving a standard method of treatment and with a stable response to BTX injection, for participation in other protocols on movement disorders and on the responses to BTX injection.
Key Dates
- Start date
- Oct 26, 1989
- Status verified
- Mar 2026
Study Design
- Enrollment
- 2,000 participants (estimated)
Arms
- Arm: PatientsPatients 2 years and older, will be eligible for participation if they have a disorder that, in the judgment of the treating physician, might be amenable to treatment with BTX. Applicable disorders include but are not limited to dystonia, hemifacial spasm, blepharospasm, tremor, spasmodic dysphonia, tics, vocal fold tremor, oral lingual dyskinesia, tardive dyskinesia, spasticity, and spasmodic dysphonia.
Primary Outcome Measure
Study Natural History- data analysis [ Time Frame: Ongoing ]
Central Contacts
- Vivian S Koo(301) 435-8518
- Debra J Ehrlich, M.D.(301) 443-7888
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | Maryland | 20892 | For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 |
Find similar trials in Bethesda, MD
Related Studies
- A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor ComplicationsRecruiting · InSightec · Baltimore, Maryland
- Neurophysiological, Behavioral, and Cognitive Networks in Movement DisordersRecruiting · University of Alabama at Birmingham · Birmingham, Alabama
- Abbott DBS Post-Market Study of Outcomes for Indications Over TimeRecruiting · Abbott Medical Devices · Tucson, Arizona
- SLC13A5 Deficiency Natural History Study - Remote OnlyEnrolling By Invitation · TESS Research Foundation · Palo Alto, California